Humanized anti-CXCR5 antibodies, derivatives thereof and their uses

Details for Australian Patent Application No. 2008296538 (hide)

Owner Sanofi-Aventis

Inventors Lee, Renata; Ruetsch, Norman; Cameron, Beatrice; Oligino, Thomas; Mikol, Vincent; Baurin, Nicolas; Allen, Elizabeth

Agent Watermark

Pub. Number AU-A-2008296538

PCT Pub. Number WO2009/032661

Priority 60/968,792 29.08.07 US

Filing date 27 August 2008

Wipo publication date 12 March 2009

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

25 March 2010 PCT application entered the National Phase

  PCT publication WO2009/032661 Priority application(s): WO2009/032661

3 June 2010 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 14 Apr 2010

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008296545-2 -biphenylamino-4 -aminopyrimidine derivatives as kinase inhibitors

2008296532-Method and composition for making an orally disintegrating dosage form